loadpatents
Patent applications and USPTO patent grants for ZAMPONI; Gerald W..The latest application filed is for "use of t-type calcium channel blocker for treating pruritus".
Patent | Date |
---|---|
Use Of T-type Calcium Channel Blocker For Treating Pruritus App 20220226299 - ZAMPONI; Gerald W. ;   et al. | 2022-07-21 |
Products And Methods Associated With Multiple Sclerosis As A Transmissible Protein Misfolding Disorder App 20200229407 - Stys; Peter ;   et al. | 2020-07-23 |
Treatment of pain by inhibition of USP5 de-ubiquitinase Grant 9,993,522 - Garcia-Caballero , et al. June 12, 2 | 2018-06-12 |
Treatment Of Pain By Inhibition Of Usp5 De-ubiquitinase App 20150231203 - Garcia-Caballero; Agustin ;   et al. | 2015-08-20 |
Calcium channel blockers Grant 7,666,865 - Snutch , et al. February 23, 2 | 2010-02-23 |
Calcium channel blockers App 20070185105 - Snutch; Terrance P. ;   et al. | 2007-08-09 |
Preferentially substituted calcium channel blockers Grant 7,186,726 - Snutch , et al. March 6, 2 | 2007-03-06 |
Preferentially substituted calcium channel blockers Grant 7,064,128 - Snutch , et al. June 20, 2 | 2006-06-20 |
Calcium channel blockers comprising two benzhydril moieties App 20060084660 - Snutch; Terrance P. ;   et al. | 2006-04-20 |
Calcium channel blockers comprising two benzhydril moieties Grant 6,951,862 - Snutch , et al. October 4, 2 | 2005-10-04 |
Calcium channel blockers comprising two benzhydril moieties Grant 6,949,554 - Snutch , et al. September 27, 2 | 2005-09-27 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine Grant 6,943,168 - Snutch , et al. September 13, 2 | 2005-09-13 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine App 20040266784 - Snutch, Terrance P. ;   et al. | 2004-12-30 |
Calcium channel blockers comprising two benzhydril moieties App 20040259866 - Snutch, Terrance P. ;   et al. | 2004-12-23 |
Calcium channel blockers comprising two benzhydril moieties App 20040209872 - Snutch, Terrance P. ;   et al. | 2004-10-21 |
Preferentially substituted calcium channel blockers App 20040192703 - Snutch, Terrance P. ;   et al. | 2004-09-30 |
Preferentially substituted calcium channel blockers App 20040147529 - Snutch, Terrance P. ;   et al. | 2004-07-29 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine App 20040044004 - Snutch, Terrance P. ;   et al. | 2004-03-04 |
Calcium channel inhibitors comprising benzhydril spaced from piperazine App 20040034035 - Snutch, Terrance P. ;   et al. | 2004-02-19 |
NCAGE Code | L6012 | ZAMPONI GERALD W |
CAGE Code | L6012 | ZAMPONI, GERALD W |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.